2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Evaluation of Natural Killer Cell Activation by NK Cell-Specific Interferon-Gamma-Releasing Assay

J. Ryu,¹ K. Park,¹ Y. Kim,² E.-J. Oh.²
Evaluation of Preformed Anti-HLA Antibody of "Unknown Origin" after Kidney Transplant in a Brazilian Center

D. Glasberg,¹ D. Monteiro de Carvalho,² T. Matuck,² G. Fabricio-Silva,³ M. Barbosa,¹ A. Borela,¹ L. Christiani,¹ R. Malta,¹ L. Porto.³
Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients

X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.
Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients

E. Aldag, S. Farrell, R. Pedersen, A. Sahajpal, J. Clendenon, V. Gunabushanam, D. Kramer.
Evaluation of the Gastrointestinal Tract as a Potential Route of Primary Polyomavirus Infection

G. Huang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
Evaluation of the Use of Leflunomide for the Prevention of BK Nephropathy in Renal Transplant Recipients- A Single Center Experience

S. Jonchhe, E. Hollinger, S. Jensik, O. Olaitan, A. Hodowanec, M. Hertl, S. Fayek, E. Chan, C. Pullum, N. Alvey.
Everolimus and Early Calcineurin Inhibitor Withdrawal Is Associated With Superior Renal Function: 5-Year Follow-Up of the Randomized PROTECT Liver Transplantation Study

M. Sterneck, G. Kaiser, N. Heyne, N. Richter, F. Rauchfuss, A. Pascher, P. Schemmer, L. Fischer, C. Klein, S. Nadalin, F. Lehner, U. Settmacher, D. Gotthardt, M. Loss, S. Ladenburger, P. Wimmer, M. Dworak, H. Schlitt.
Everolimus Conversion to Treat BK Virus Infection in Kidney Transplant Recipients

D. Wojciechowski, A. Webber, S. Chandran, F. Vincenti.
Everolimus Initiation Immediately After Liver Transplantation: A Single-Center Experience

U. Herden, A. Galante, S. Pischke, L. Fischer, J. Li, M. Koch, E. Achilles, B. Nashan, M. Sterneck.
Everolimus Plus Reduced-Exposure Calcineurin Inhibitor Versus Mycophenolate Mofetil Plus Standard-Exposure Calcineurin Inhibitor: 2-Year Results in Living Donor Kidney Transplant Recipients

Y. Watarai,¹ N. Akutsu,² K. Saito,³ Y. Nakagawa,³ O. Kamisawa,⁴ T. Kenmochi.⁵

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z